Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing Duramesh and Polydioxanone for Closing Abdominal Surgery Incisions

Official title: A Prospective Randomized Controlled Trial Comparing Duramesh™ With Polydioxanone Suture for Laparotomy Closure

Run by University Hospital, Ghent · NCT05804136 · Data updated 2026-11-12

This study is testing whether using Duramesh or polydioxanone stitches for closing abdominal surgery cuts leads to fewer problems and better recovery for patients.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment230 (estimated)
SponsorUniversity Hospital, Ghent
Academic / other
Locations1 site (Ghent, Oost-Vlaanderen)
StatusRecruiting
StartedMarch 31, 2023
Main results expectedJune 30, 2026
Study endsJuly 31, 2027
Registry record updatedApril 17, 2025
Trial IDNCT05804136 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 or older who require a laparotomy of 5 cm or greater.

Probably not a fit

Patients with existing hernias at the laparotomy site or those with a life expectancy of less than one year may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical investigation aims to compare the effectiveness of Duramesh closure versus polydioxanone suture for laparotomy closure after abdominal surgery. The primary focus is to assess early surgical site events within one month post-surgery, while secondary outcomes include the incidence of incisional hernias after one year, pain levels, and overall patient satisfaction. Participants will undergo a laparotomy of at least 5 cm, and their outcomes will be monitored for a year to evaluate the performance of each closure method.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced hernia rates for patients undergoing abdominal surgery.

How similar studies have gone: Previous studies have shown promising results with similar closure techniques, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 or greater
* Abdominal laparotomy 5 cm in length or greater, either midline or non-midline
* Isolated ostomy site takedown with or without parastomal hernia
* Patient accepts participation and gives informed consent
* Patient and investigator signed and dated the informed consent form prior to the index-procedure

Exclusion Criteria:

* Pregnancy
* Presence of clinically recognized hernia at laparotomy site (parastomal hernia noted at time of ostomy site takedown is not an exclusion criterion. Subclinical incidental small hernia \< 1 cm in greatest dimension found at the time of a laparotomy is not an automatic exclusion criterion)
* Prior hernia repair at laparotomy site
* Use of planar mesh in addition to sutures for closure
* CDC IV dirty or infected wound that causes the surgeon to leave the abdominal wall or skin incision open
* Life expectancy less than 1 year
* Patient is unable / unwilling to provide informed consent
* Patient is unable to comply with the protocol or proposed follow-up visits
* Patient is enrolled in another abdominal wall study

Where it's running

  • UZ Gent
    Ghent, Oost-Vlaanderen, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.